BioGaia AB (publ)
BGLAF
$8.87
-$0.8517-8.76%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 133.27M | 134.51M | 128.70M | 128.91M | 122.94M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 133.27M | 134.51M | 128.70M | 128.91M | 122.94M |
| Cost of Revenue | 36.23M | 37.05M | 34.01M | 33.75M | 32.82M |
| Gross Profit | 97.04M | 97.46M | 94.69M | 95.17M | 90.12M |
| SG&A Expenses | 44.94M | 43.87M | 41.60M | 40.43M | 39.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 2.28M | -1.19M | -1.19M | -1.19M | -1.19M |
| Total Operating Expenses | 93.16M | 89.73M | 83.98M | 82.51M | 81.51M |
| Operating Income | 40.11M | 44.78M | 44.72M | 46.40M | 41.42M |
| Income Before Tax | 37.10M | 42.33M | 40.94M | 48.27M | 44.62M |
| Income Tax Expenses | 8.09M | 9.11M | 8.98M | 10.44M | 9.51M |
| Earnings from Continuing Operations | 29.01 | 33.21 | 31.96 | 37.83 | 35.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.01M | 33.21M | 31.96M | 37.83M | 35.10M |
| EBIT | 40.11M | 44.78M | 44.72M | 46.40M | 41.42M |
| EBITDA | 42.55M | 47.19M | 47.12M | 48.68M | 43.74M |
| EPS Basic | 0.29 | 0.33 | 0.32 | 0.37 | 0.35 |
| Normalized Basic EPS | 0.27 | 0.30 | 0.29 | 0.31 | 0.28 |
| EPS Diluted | 0.29 | 0.33 | 0.32 | 0.37 | 0.35 |
| Normalized Diluted EPS | 0.27 | 0.30 | 0.29 | 0.31 | 0.28 |
| Average Basic Shares Outstanding | 404.38M | 404.20M | 404.02M | 403.93M | 403.93M |
| Average Diluted Shares Outstanding | 404.41M | 404.24M | 404.06M | 403.96M | 403.94M |
| Dividend Per Share | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 |
| Payout Ratio | 224.65% | 196.22% | 203.95% | 172.26% | 79.26% |